[In response to a question, he said it was impossible to give] any reliable estimate ... All those estimates are just speculation. |
[Merck makes no apologies, though, for focusing on drug making rather than deal making.] We're distinguished by the excellence of our research, ... Investing in that capability is the best opportunity for us to create shareholder value. |
After we looked at the data, within less than a week, we withdrew the drug voluntarily. |
By focusing intense efforts on Botswana, we hope to show what can be achieved with comprehensive efforts across the entire spectrum of care, from voluntary testing and counseling and education to the provision of increased access to medicines and appropriate monitoring of treatment, |
He's an excellent candidate, ... Dick's long tenure here at Merck will make this is a smooth transition process. |
He's an excellent candidate. Dick's long tenure here at Merck will make this is a smooth transition process. |
Income growth for the quarter and the year reflects strong worldwide sales volume gains, as well as manufacturing productivity improvements, |
Income growth for the quarter was driven by strong overall unit volume gains, |
No, I'm not telling you that at all. |
Our goal is not to be just one of the largest pharmaceutical companies, but also to be one of the fastest growing, |
Remarkably, for the first 18 months there was no difference so it was consistent with all our other data and at 18 months the risk started to build and we saw the data, we withdrew the drug, |
subject to market conditions. |
The unfavorable effects of inflation, net of price, and exchange were partially offset by cost controls and productivity improvements in manufacturing, selling and general and administrative expenses. |
very strong financially, with very strong cash flow. |
We are resuming growth in 2003, |